pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,889 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 201 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: pdufa×type: approval×type: phase readout×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa201
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07312786: Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors

    Sponsor: Nova Scotia Health Authority. Phase: NA. Conditions: Breast Cancer Survivor, Colorectal Cancer Survivors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05760885: Multisensory Augmentation for Post-stroke Standing Balance

    Sponsor: VA Office of Research and Development. Phase: EARLY_PHASE1. Conditions: Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05016843: The Study of Internet-delivered, Transdiagnostic Treatments for Anxiety and Depression

    Sponsor: Stockholm University. Phase: NA. Conditions: Anxiety Disorders, Depression

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07528326: The TRICURE US IDE Pivotal Study

    Sponsor: TRiCares. Phase: NA. Conditions: Tricuspid Regurgitation (TR)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07442526: AGECTO Study: PCI vs. Optimal Medical Therapy for CTO in the Octogenarian Patients

    Sponsor: San Luigi Gonzaga Hospital. Phase: . Conditions: Coronary Artery Disease (CAD), Chronic Total Occlusion (CTO), Percutaneous Coronary Intervention (PCI), Optimal Medical Therapy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06864026: A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

    Sponsor: Eli Lilly and Company. Phase: PHASE4. Conditions: Psoriatic Arthritis, Overweight or Obesity

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07463443: Effectiveness of Chatbot for Improving Caregiving Outcomes in Primary Caregivers of Geriatric Pneumonia Patients: A Study on Knowledge, Attitude and Practice.

    Sponsor: Taipei Veterans General Hospital, Taiwan. Phase: NA. Conditions: Pneumonia, Family Caregivers, Knowledge, Attitudes, Practice, Chatbot, Geriatric Patient

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06648226: Food Swaps to Improve the Healthfulness and Reduce the Carbon Footprint of Grocery Purchases

    Sponsor: Stanford University. Phase: NA. Conditions: Food Selection, Nutrition, Food Preferences, Dietary Habits, Sustainability, Healthy Diet

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07586917: Optimizing Pregnancy and Treatment Interventions for Moms 3.0

    Sponsor: University of Utah. Phase: NA. Conditions: Opioid Abuse (Disorder), Stimulant Use Disorders

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07269340: Mandala Painting During Chemotherapy

    Sponsor: Uludag University. Phase: NA. Conditions: Mandala Painting, Chemotherapy, Vomiting, Anxiety, Comfort, Nursing Care

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07379489: Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma

    Sponsor: Tongji Hospital. Phase: . Conditions: HCC, Adjuvant Therapy, Recurrence, Immune Checkpoint Inhibitor

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07592468: Intraoperative CO₂ (Carbon Dioxide)

    Sponsor: Baylor Research Institute. Phase: NA. Conditions: Wound Edges

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04234568: Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Metastatic Digestive System Neuroendocrine Neoplasm, Metastatic Neuroendocrine Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04971850: Sleep-disordered Breathing and Neurocognitive Assessment in Children and Young Adults

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Sleep-disordered Breathing (SDB)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00044174: Dyadic Interactions in Depressed and Non-Depressed Mothers and Their Infants

    Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05874492: Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Radiotherapy for Breast Cancer or UADT (Upper Aerodigestive Tract) Cancer

    Sponsor: Association Francaise pour la Recherche Thermale. Phase: NA. Conditions: Fibrosis, Breast Cancer, Head and Neck Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02387736: DBT for Chronically Self-harming Individuals With BPD: Evaluating the Clinical & Cost Effectiveness of a 6 mo. Treatment

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Borderline Personality Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05642611: Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

    Sponsor: SWOG Cancer Research Network. Phase: PHASE3. Conditions: Malignant Solid Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07516834: Three Dimensional Gait Analysis and Electromyography After Stabilisation of Thoracolumbar Spine Fractures Focusing on Possible Temporal Diferences in Physiological Gait Recovery Through Comparison of Open and Minimally Invasive Approaches.

    Sponsor: Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.. Phase: NA. Conditions: Spine Fracture

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07105709: Open-label Extension Study in Participants With Early Alzheimer's Disease

    Sponsor: GlaxoSmithKline. Phase: PHASE2. Conditions: Alzheimer's Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05634499: A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer

    Sponsor: Hoffmann-La Roche. Phase: PHASE2. Conditions: Endometrial Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02754544: Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Brain Neoplasm, Metastatic Malignant Neoplasm in the Brain, Recurrent Brain Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05665244: Laryngeal Cryotherapy for Refractory Neurogenic Cough

    Sponsor: University of Texas Southwestern Medical Center. Phase: . Conditions: Upper-Airway Cough Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07431034: Internet-Based Cognitive Behavioral Therapy for Insomnia in Persian-Speaking Adults

    Sponsor: Rasool Hamidi Choolabi. Phase: NA. Conditions: Insomnia Disorder, Chronic Insomnia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06575699: Rectus Sheath Block for Analgesia After Gynecological Laparotomy

    Sponsor: Duke University. Phase: PHASE4. Conditions: Gynecologic Surgical Procedures

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04736199: Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer

    Sponsor: Bayer. Phase: PHASE3. Conditions: Prostatic Neoplasms

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06346132: Effect of Virtual Reality on Patient's Comfort During Cardiac Electronic Device Implantation.

    Sponsor: Schlotterbeck Hervé. Phase: NA. Conditions: Virtual Reality, Medical Device, Local Anesthesia, Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07627763: Prospective Dynamic Cohort Study of Phenotypic Profiles in Patients With Chronic Obstructive Pulmonary Disease

    Sponsor: Initiatives Bronchopneumopathie Chronique Obstructive (BPCO). Phase: . Conditions: COPD

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07047521: A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults

    Sponsor: Takeda. Phase: PHASE3. Conditions: Dengue Fever

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07019116: Efficacy of Artificial Intelligence for Gatekeeping in Referrals to Specialized Care

    Sponsor: Hospital de Clinicas de Porto Alegre. Phase: NA. Conditions: Primary Care, Primary Care Patients With Chronic Conditions

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06275906: Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.

    Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis. Phase: NA. Conditions: NAFLD, Obesity, IBS

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07299006: Evaluation of Paro, a Therapeutic Assistance Robot in Analgesic Management During the Placement of a Peripheral Intravenous Line in Infants and Children.

    Sponsor: Fondation Lenval. Phase: NA. Conditions: Pain Management

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07051304: Video-Based Versus Numerical Pain Assessment in Postoperative Patients: A Pilot Study

    Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: . Conditions: Pain Assessment Scales

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05446584: Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History

    Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE2. Conditions: Mild Cognitive Impairment, Amnestic Mild Cognitive Disorder, Amnestic Mild Cognitive Impairment, Mild Traumatic Brain Injury, Concussion, Brain

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07318584: Cefotetan Therapy for Escherichia Coli Infections

    Sponsor: Oregon Health and Science University. Phase: PHASE2. Conditions: E Coli Infection, ESBL Producing E.Coli

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07218133: Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery

    Sponsor: Alexander T. Yahanda. Phase: NA. Conditions: Spinal Fusion, Hyperglycemia, Postoperative Pain Management, Postoperative Care, Spine Disease, Neurologic Deficits, Neurological Disorder, Inflammation, Spine Condition, Spinal (Fusion) Surgery, Cytokine Levels, Spine Fusion

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03602833: Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma

    Sponsor: Royal Marsden NHS Foundation Trust. Phase: PHASE1. Conditions: Soft-tissue Sarcoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07586033: Prevalence and Functional Impact of Hand and Wrist Symptoms in Ice Hockey Players

    Sponsor: Dalarna County Council, Sweden. Phase: . Conditions: Hand, Wrist, Overuse Injury, Ice Hockey Players

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07462533: Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing

    Sponsor: Goldman, Butterwick, Fitzpatrick and Groff. Phase: PHASE2. Conditions: Skin Laxity

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04279847: Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

    Sponsor: Incyte Corporation. Phase: PHASE1. Conditions: Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome, Myeloproliferative Neoplasm, Relapsed or Refractory Primary Myelofibrosis, Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis), ET (Essential Thrombocythemia)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06627647: A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC

    Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Non-squamous Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07439848: Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis

    Sponsor: PT. Prodia Stem Cell Indonesia. Phase: PHASE1. Conditions: Acute Respiratory Distress Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07580248: Effects of Supplementation on Performance in Football Players

    Sponsor: Krzysztof Mizera. Phase: NA. Conditions: Physical Performance, Cognitive Performance

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06641765: Continuous Glucose Monitoring in Dialysis Patients With Diabetes

    Sponsor: Bo Feldt-Rasmussen. Phase: NA. Conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Continuous Glucose Monitoring, Haemodialysis, Peritoneal Dialysis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05319067: Study of Gut Microbiota Diversity in Children Aged 1-3 Years on Prolonged Antibiotic Prophylaxis for Grade 3 or Higher Vesicoureteral Reflux Compared With 2 Age-matched Control Groups

    Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Vesicoureteral Reflux 3

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04150900: 1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck

    Sponsor: University of Maryland, Baltimore. Phase: PHASE2. Conditions: Squamous Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06053411: Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac

    Sponsor: Washington State University. Phase: EARLY_PHASE1. Conditions: Interaction

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05694871: Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

    Sponsor: Alliance for Clinical Trials in Oncology. Phase: PHASE2. Conditions: Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma, Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Unresectable Dedifferentiated Liposarcoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06845371: MELODY Registry Follow-Up Study

    Sponsor: University Hospital Tuebingen. Phase: . Conditions: Congenital Heart Disease (CHD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06377371: Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

    Sponsor: Weill Medical College of Cornell University. Phase: PHASE4. Conditions: Meningioma

    full page →ctgov ↗
    ← prev
    page 58 of 98
    next →